Dissociation between bone resorption and bone formation in osteopenic transgenic mice

  1. David A. Corral*,,,
  2. Michael Amling,§,,,
  3. Matthias Priemel,
  4. Evelyn Loyer**,
  5. Sebastien Fuchs*,
  6. Patricia Ducy*,‡‡,
  7. Roland Baron, and
  8. Gerard Karsenty*,‡‡,††
  1. Departments of *Molecular Genetics, Urology, and **Radiology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030; Departments of §Trauma Surgery and Bone Pathology, Hamburg University, Hamburg 20246, Germany; Department of Cell Biology and Orthopedics, Yale University School of Medicine, New Haven, CT 06510; and ‡‡Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030
  1. Communicated by Pierre Chambon, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Strasbourg, France (received for review July 22, 1998)

Abstract

Bone mass is maintained constant in vertebrates through bone remodeling (BR). BR is characterized by osteoclastic resorption of preexisting bone followed by de novo bone formation by osteoblasts. This sequence of events and the fact that bone mass remains constant in physiological situation lead to the assumption that resorption and formation are regulated by each other during BR. Recent evidence shows that cells of the osteoblastic lineage are involved in osteoclast differentiation. However, the existence of a functional link between the two activities, formation and resorption, has never been shown in vivo. To define the role of bone formation in the control of bone resorption, we generated an inducible osteoblast ablation mouse model. These mice developed a reversible osteopenia. Functional analyses showed that in the absence of bone formation, bone resorption continued to occur normally, leading to an osteoporosis of controllable severity, whose appearance could be prevented by an antiresorptive agent. This study establishes that bone formation and/or bone mass do not control the extent of bone resorption in vivo.

Footnotes

  • D.A.C. and M.A. contributed equally to this work.

  • †† To whom reprint requests should be addressed at Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. e-mail: karsenty{at}bcm.tmc.edu.

  • A Commentary on this article begins on page 13361.

  • ABBREVIATIONS:
    BMC,
    bone marrow cell;
    BR,
    bone remodeling;
    GCV,
    ganciclovir;
    tg,
    transgenic;
    wt,
    wild type
« Previous | Next Article »Table of Contents